XTX Topco’s Latigo Biotherapeutics LTGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Buy
+13,238
New +$279K ﹤0.01% 3042

Other funds holding LTGO

XTX Topco's LTGO Position: Q3 2026 in Review

XTX Topco opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 13,238 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3042 among its holdings.

58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.

  • XTX Topco held 13,238 shares of Latigo Biotherapeutics worth $221K as of Q3 2026.
  • Latigo Biotherapeutics was a new XTX Topco position in Q3 2026.
  • Latigo Biotherapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3042 holding.
  • 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.

Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.